BioCentury
ARTICLE | Clinical News

Convivia: Phase IIa data

November 17, 2008 8:00 AM UTC

In a double-blind, dose-escalation, U.S. Phase IIa trial in 32 patients of Japanese descent with ALDH2 deficiency, oral Convivia significantly reduced heart palpitations following alcohol consumption....